Competitors Push New Data In Coverage Battle For T-Wave Alternans Tests
This article was originally published in The Gray Sheet
Executive Summary
Industry and physician stakeholders say CMS missed a key study in considering its coverage policy for noninvasive tests that help assess a patient's need for an implantable defibrillator. Competing test makers have different views on how the new data should be interpreted